Additive Effect of rPb27 Immunization and Chemotherapy in Experimental Paracoccidioidomycosis
2011

Combining rPb27 Immunization with Chemotherapy for Paracoccidioidomycosis Treatment

Sample size: 12 publication 10 minutes Evidence: moderate

Author Information

Author(s): Viviane C. Fernandes, Estefânia M. N. Martins, Jankerle N. Boeloni, Juliana B. Coitinho, Rogéria Serakides, Alfredo M. Goes

Primary Institution: Universidade Federal de Minas Gerais, Belo Horizonte, Brazil

Hypothesis

Can rPb27 immunization enhance the effectiveness of chemotherapy in treating Paracoccidioidomycosis?

Conclusion

The study found that rPb27 immunization combined with fluconazole chemotherapy effectively reduced fungal load and improved treatment outcomes in mice with Paracoccidioidomycosis.

Supporting Evidence

  • Immunization with rPb27 and fluconazole led to a 60% reduction in fungal load in the lungs after 40 days.
  • Histopathological analysis showed reduced lesions in the liver and spleen of treated mice.
  • Significant levels of anti-rPb27 specific IgG were detected in immunized mice.

Takeaway

Researchers tested a new vaccine with a medicine to help mice fight a fungal infection better. It worked well at first but needed more time to keep helping.

Methodology

BALB/c mice were infected with P. brasiliensis and then immunized with rPb27 and treated with fluconazole; fungal loads were measured in organs after treatment.

Limitations

The control of fungal growth in the lungs was lost after 90 days, indicating a need for longer treatment duration.

Participant Demographics

Adult male BALB/c mice, 6-8 weeks old.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1371/journal.pone.0017885

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication